IBT — International Biotechnology Trust Income Statement
0.000.00%
Last trade - 00:00
FinancialsConservativeSmall Cap
- £232.46m
- £264.94m
- £12.06m
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | -13.8 | 57 | 32.1 | -18 | 12.1 |
Cost of Revenue | |||||
Gross Profit | -16.6 | 54.6 | 29.1 | -21.1 | 8.49 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 3.66 | 3.43 | 4.05 | 4.36 | 5.13 |
Operating Profit | -17.4 | 53.6 | 28 | -22.3 | 6.93 |
Net Income Before Taxes | -17.4 | 53.6 | 28 | -22.3 | 6.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.5 | 53.4 | 27.9 | -22.5 | 6.81 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.5 | 53.4 | 27.9 | -22.5 | 6.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.5 | 53.4 | 27.9 | -22.5 | 6.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.463 | 1.39 | 0.689 | -0.547 | 0.168 |
Dividends per Share |